Elanco Animal Health Incorporated (ELAN)

Elanco Animal Health Incorporated (ELAN) is a healthcare company (drug manufacturers - specialty & generic) based in the United States. The share price is $25.98, down 1.65% on the day, which values the company at $12.98B. Price as of 17 Nov 2026, 17:42 UTC, from Yahoo Finance.

Key facts

Share price
$25.98−1.65% today
Market value
$12.98B
Forward P/E
20.1×
Funk Score
28/100
Against its own history
Above its usual priceusual price $22.63
200-week average
$16.1061% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Elanco Animal Health Incorporated in more detail

ELAN trades at 20.1× next year's expected earnings, 2.5× sales. Measured against its own history, the price is 15% above what its usual multiples would imply ($22.63) — above its usual price. It sits 61% above its 200-week average of $16.10.

Over the last five fiscal years Elanco Animal Health Incorporated has compounded revenue 7.6% a year. Its Funk Score is 28 out of 100 (financial strength 2.0, profitability 1.9, growth 5.0, value 2.2, each out of 10).

Worth checking: Altman Z in the distress zone; Thin interest cover.

5 of the superinvestors tracked here hold ELAN, including Dodge & Cox team (0.7% of the portfolio), Primecap team (0.6% of the portfolio), Charles Brandes (founder) (0.5% of the portfolio).

Superinvestors holding ELAN

5 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:ELAN vs BAX (Elanco Animal Health Incorporated vs Baxter International)ELAN vs BTSG (Elanco Animal Health Incorporated vs BrightSpring Health Services)ELAN vs EHC (Elanco Animal Health Incorporated vs Encompass Health)ELAN vs SNN (Elanco Animal Health Incorporated vs Smith & Nephew)ELAN vs GKOS (Elanco Animal Health Incorporated vs Glaukos)

All health care companies by market valueLargest companies in the United StatesAll stocks A–Z

Elanco Animal Health Incorporated (ELAN): questions and answers

What is ELAN's PEG ratio?

Elanco Animal Health Incorporated's PEG ratio is 4.04 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is Elanco Animal Health Incorporated's market cap?

Elanco Animal Health Incorporated is valued at $12.98B at a share price of $25.98.

Is ELAN overvalued or undervalued?

Against its own history, ELAN is above its usual price: the price is 15% above the $22.63 implied by the median multiples it has traded at (price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ELAN above its 200-week moving average?

Yes. ELAN is 61.3% above its 200-week average of $16.10. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Elanco Animal Health Incorporated growing?

Over the last five fiscal years Elanco Animal Health Incorporated's revenue grew 7.6% a year.

Does ELAN pay a dividend?

Elanco Animal Health Incorporated does not currently pay a regular dividend.

Cite this page

Funkfolio, “Elanco Animal Health Incorporated (ELAN) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ELAN

Underlying data: Yahoo Finance; company filings with the SEC.